Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Creabilis expands senior management team

This article was originally published in Scrip

Executive Summary

Earlier in August, Creabilis hired David Roblin from Pfizer as chief medical officer (, 9 August), and now, the company has appointed three more ex-Pfizer employees to its senior management team. Alex Leech joins Creabilis as vice-president and head of finance and operations, and previously served as head of operations at Solace Pharmaceuticals, and head of European project management for the Pfizer R&D organisation. James Sandy was most recently development team leader at Pfizer, and joins Creabilis as senior vice-president and head of development, and Dr Peter Spargo, former head of chemical process R&D for Pfizer, joins as senior vice-president of CMC, the same role he held recently at Novexel.

You may also be interested in...

Almirall launches Constella in six European markets

Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.

Dermira raises $35m in series B

Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.

Clovis ups public offering to $240m

Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.

Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts